Daniel M. Junius, Director at IDEXX LABORATORIES INC /DE (IDXX), sold 4,374 shares at $511.68 ($2.2M) on 2023-02-16, disclosed to the SEC on 2023-02-17.
Seasonal sale ($2.2M) by Director — this insider has traded IDXX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $511.68 | 2,187 | $1.1M | 50.0% |
| 2 | $511.68 | 2,187 | $1.1M | 50.0% |
| Total | $511.68 avg | 4,374 | $2.2M | 100% |
| Filing → |
| IDXX | SELL | 2022-12-07 | $2.6M | — | Filing → |
| GLYC | BUY | 2022-11-18 | $37K | — | Filing → |
| IDXX | SELL | 2021-08-12 | $3.3M | — | Filing → |